Cipla receives final approval for generic version of Migranal with a Competitive Generic Therapy Designation Read more
Gilead signs Voluntary Licensing Agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan for remdesivir Read more
While the market is bleeding, pharma sector has withstood the lock-down. Can it be a good bet for investors? Read more